loader
Please Wait
Applying Filters...

Approved Drug Products containing Pregn-4-ene-7,21-dicarboxylic acid, 9,11-epoxy-17-hydroxy-3-oxo-, gamma-lactone, methyl ester, (7alpha,11alpha,17alpha)- listed with Health Canada. Original Data : Health Canada Website

Menu
$ API Ref.Price (USD/KG) : 2,242Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2BGP PHARMA ULC

02 2JAMP PHARMA CORPORATION

03 2MINT PHARMACEUTICALS INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

EPLERENONE

Brand Name : INSPRA

Dosage Form : TABLET

Dosage Strength : 25MG

Packaging : 30

Approval Date :

Application Number : 2323052

Regulatory Info : Prescription

Registration Country : Canada

blank

02

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

EPLERENONE

Brand Name : INSPRA

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging : 30

Approval Date :

Application Number : 2323060

Regulatory Info : Prescription

Registration Country : Canada

blank

03

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

EPLERENONE

Brand Name : JAMP EPLERENONE

Dosage Form : TABLET

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number : 2543389

Regulatory Info : Prescription

Registration Country : Canada

blank

04

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

EPLERENONE

Brand Name : JAMP EPLERENONE

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 2543397

Regulatory Info : Prescription

Registration Country : Canada

blank

05

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

EPLERENONE

Brand Name : MINT-EPLERENONE

Dosage Form : TABLET

Dosage Strength : 25MG

Packaging : 30/90/100

Approval Date :

Application Number : 2471442

Regulatory Info : Prescription

Registration Country : Canada

blank

06

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

EPLERENONE

Brand Name : MINT-EPLERENONE

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging : 30/90/100

Approval Date :

Application Number : 2471450

Regulatory Info : Prescription

Registration Country : Canada

blank